ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization

被引:169
作者
DiDonato, M
Craig, L
Huff, ME
Thayer, MM
Cardoso, RMF
Kassmann, CJ
Lo, TP
Bruns, CK
Powers, ET
Kelly, JW
Getzoff, ED
Tainer, JA
机构
[1] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
ALS; Lou Gehrig's disease; superoxide dismutase; aggregation; neurodegenerative;
D O I
10.1016/S0022-2836(03)00889-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many point mutations in human Cu,Zn superoxide dismutase (SOD) cause familial amyotrophic lateral sclerosis (FALS), a fatal neurodegenerative disorder in heterozygotes. Here we show that these mutations cluster in protein regions influencing architectural integrity. Furthermore, crystal structures of SOD wild-type and FALS mutant H43R proteins uncover resulting local framework defects. Characterizations of beta-barrel (H43R) and dimer interface (A4V) FALS mutants reveal reduced stability and drastically increased aggregation propensity Moreover, electron and atomic force microscopy indicate that these defects promote the formation of filamentous aggregates. The filaments resemble those seen in neurons of FALS patients and bind both Congo red and thioflavin T, suggesting the presence of amyloid-like, stacked beta-sheet interactions. These results support free-cysteine-independent aggregation of FALS mutant SOD as an integral part of FALS pathology. They furthermore provide a molecular basis for the single FALS disease phenotype resulting from mutations of diverse side-chains throughout the protein: many FALS mutations reduce structural integrity, lowering the energy barrier for fibrous aggregation. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:601 / 615
页数:15
相关论文
共 76 条
  • [11] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [12] Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase
    Cardoso, RMF
    Thayer, MM
    DiDonato, M
    Lo, TP
    Bruns, CK
    Getzoff, ED
    Tainer, JA
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (02) : 247 - 256
  • [13] Charcot J, 1869, Arch Physiol Neurol Pathol, V2, P744
  • [14] Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immunohistochemical study
    Chou, SM
    Wang, HS
    Komai, K
    [J]. JOURNAL OF CHEMICAL NEUROANATOMY, 1996, 10 (3-4) : 249 - 258
  • [15] TOXIC MUTANTS IN CHARCOTS SCLEROSIS
    CLEVELAND, DW
    LAING, N
    HURSE, PV
    BROWN, RH
    [J]. NATURE, 1995, 378 (6555) : 342 - 343
  • [16] Oxidation versus aggregation - how do SOD1 mutants cause ALS?
    Cleveland, DW
    Liu, J
    [J]. NATURE MEDICINE, 2000, 6 (12) : 1320 - 1321
  • [17] From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
    Cleveland, DW
    Rothstein, JD
    [J]. NATURE REVIEWS NEUROSCIENCE, 2001, 2 (11) : 806 - 819
  • [18] Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-β peptide
    Cottingham, MG
    Hollinshead, MS
    Vaux, DJT
    [J]. BIOCHEMISTRY, 2002, 41 (46) : 13539 - 13547
  • [19] Crow JP, 1997, J NEUROCHEM, V69, P1936
  • [20] Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis
    Cudkowicz, ME
    McKennaYasek, D
    Sapp, PE
    Chin, W
    Geller, B
    Hayden, DL
    Schoenfeld, DA
    Hosler, BA
    Horvitz, HR
    Brown, RH
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (02) : 210 - 221